Aprea Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $561 | $380 | $14 |
Gross Profit | 556 | 374 | 9 |
EBITDA | -3,846 | -3,143 | -3,438 |
EBIT | -3,852 | -3,149 | -3,443 |
Net Income | -3,470 | -2,810 | -3,443 |
Net Change In Cash | 561 | 380 | 14 |
Free Cash Flow | -3,546 | -3,943 | -3,871 |
Cash | 28,694 | 32,369 | 21,606 |
Basic Shares | 5,937 | 4,198 | 3,736 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $583 | $0 | $0 | $0 |
Gross Profit | 576 | -186 | -271 | -229 |
EBITDA | -14,279 | -112,475 | -36,855 | -53,249 |
EBIT | -14,286 | -112,662 | -37,127 | -53,478 |
Net Income | -14,286 | -224,875 | -36,536 | -53,916 |
Net Change In Cash | 583 | 0 | 0 | 0 |
Free Cash Flow | -12,270 | -25,011 | -37,686 | -41,828 |
Cash | 21,606 | 28,786 | 53,076 | 89,017 |
Basic Shares | 3,617 | 82 | 1,064 | 1,056 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.64 |
2024-06-30 | -$0.58 |
2024-03-31 | -$0.67 |
2023-12-31 | -$0.92 |
